Prognostic Gene Signature for lung adenocarcinoma with a Higher Risk for Treatment Failure and Accelerated cell cycle and cell proliferation Pathway Activity
Z. Li, B. Li, S. Wei, X. Li, Z. Li, Y.-q. Meng, K.-R. Zhai
The paper identifies a 78-gene prognostic signature for lung adenocarcinoma that correlates with cell cycle activity and treatment response to PIM inhibitors.
bioRxiv · May 19, 2023 · PreprintCancer Biology